Tomi Numminen

Tomi Numminen is the current Chairman at Bioretec. Prior to this, they served as a Member of the Board of Directors at BBS-Bioactive Bone Substitutes Oy from March 2018 to May 2021. Numminen has also held the position of Chief Executive Officer at Bioretec Ltd. from November 2016 to March 2019, and they were a Member of the Board of Directors at Bioretec Ltd. from May 2016 to March 2019. In addition, Numminen served as a Member of the Board of Directors at Ocuspecto Oy from March 2016 to March 2018, and as Chief Executive Officer at ReBio Technologies Limited from February 2016 to November 2016. Tomi was also the Chief Operating Officer at ReBio Technologies Limited from April 2015 to January 2016. Furthermore, Numminen has been a Member of the Board of Directors at Aucor Oy since June 2013, and they held the position of Director, Business Unit at Purac Biomaterials from July 2012 to July 2014. Additionally, they have been the Chairman Of The Board Of Directors at Labrox since June 2011 and has served as a Member of the Board of Directors at Labrox since June 2011. Lastly, Numminen was the President and CEO at Vivoxid Ltd from February 2007 to July 2012.

Tomi Numminen is a Finnish economist who earned their Masters in Economics from the University of Turku / Turku School of Economics.